Analyze Diet

Topic:Vaccination

Vaccination in horses involves the administration of antigenic material to stimulate an immune response, providing protection against specific infectious diseases. This process is a key component of preventive equine healthcare, aiming to reduce the incidence and severity of illnesses such as equine influenza, tetanus, and West Nile virus. Vaccines can be administered via various routes and may contain live attenuated, inactivated, or subunit components. The immune response elicited by vaccination helps in the development of immunological memory, enabling horses to respond more effectively upon exposure to the actual pathogen. This page compiles peer-reviewed research studies and scholarly articles that explore the development, efficacy, and safety of vaccines in equine populations.
Intrinsic, management, and nutritional factors associated with equine motor neuron disease.
Journal of the American Veterinary Medical Association    November 28, 1997   Volume 211, Issue 10 1261-1267 
de la Rúa-Domènech R, Mohammed HO, Cummings JF, Divers TJ, de Lahunta A, Summers BA.To identify intrinsic, management, nutritional, and environmental risk factors associated with equine motor neuron disease (EMND) and to determine whether epidemiologic evidence supports oxidative stress as a risk factor for developing EMND. Methods: Case-control study. Methods: 87 horses with EMND and 259 control horses. Methods: Information concerning each horse's history of exposure to multiple environmental factors prior to developing EMND was obtained by means of a questionnaire or personal interview. Exposure histories of horses with EMND and control horses were compared, and the associa...
Cell-mediated cytolysis of equine herpesvirus-infected cells by leukocytes from young vaccinated horses.
Veterinary immunology and immunopathology    July 1, 1997   Volume 57, Issue 3-4 201-214 doi: 10.1016/s0165-2427(96)05749-2
Ellis JA, Steeves E, Wright AK, Bogdan JR, Davis WC, Kanara EW, Haines DM.The objective of this study was to determine whether the administration of modified-live equine herpesvirus (EHV-1) to young horses with residual maternal antibodies stimulated EHV-specific cytolytic responses, and whether these responses were crossreactive between EHV-1 and EHV-4. Eighteen clinically normal Belgian cross-foals were used in the study and were commingled in two adjacent pens. Skin biopsies were harvested from 16 foals within 24 h of birth and fibroblast cultures were established, expanded and cryopreserved. Beginning at approximately 10 weeks of age, 10 randomly chosen foals we...
Equine arteritis virus.
Theriogenology    April 15, 1997   Volume 47, Issue 6 1275-1295 doi: 10.1016/s0093-691x(97)00107-6
Glaser AL, Chirnside ED, Horzinek MC, de Vries AA.Equine arteritis virus (EAV) is a small, enveloped, positive-stranded RNA virus, in the family Arteriviridae , W.H.ich can infect both horses and donkeys. While the majority of EAV infections are asymptomatic, acutely infected animals may develop a wide range of clinical signs, including pyrexia, limb and ventral edema, depression, rhinitis, and conjunctivitis. The virus may cause abortion and has caused mortality in neonates. After natural EAV infection, most horses develop a solid, long-term immunity to the disease. Marzz and geldings eliminate the virus within 60 days, but 30 to 60% of acut...
Adverse reactions to veterinary drugs reported in Sweden during 1991-1995.
Journal of veterinary pharmacology and therapeutics    April 1, 1997   Volume 20, Issue 2 105-110 doi: 10.1046/j.1365-2885.1997.00050.x
Tjälve H.The present article gives a summary of suspected adverse reactions reported by Swedish veterinarians during the period 1991-1995. The summary shows that severe adverse drug-reactions sometimes occur in Swedish veterinary practice. In horses, several cases of acute reactions in animals treated with procaine benzylpenicillin were reported and seven horses died within a few minutes after intramuscular injections of the drug. In cattle and swine most reports referred to the use of antimicrobial agents. In dogs reactions to vaccines were the most frequently reported adverse effects. The reactions w...
Patterns of health maintenance on Michigan equine operations.
Preventive veterinary medicine    January 1, 1997   Volume 29, Issue 3 201-220 doi: 10.1016/s0167-5877(96)01075-6
Kaneene JB, Miller R, Ross W, Gilbert L.Data from two 12 month prospective monitoring programs that followed management, economics and animal health from randomly-sampled equine operations in Michigan were used to determine patterns of health maintenance. Health maintenance measures were grouped, and average uses per year were computed for the most-common measures reported: respiratory, Potomac Horse Fever, neurological and multiple-system vaccinations, deworming, and general farrier work. Factors examined for potential association with health maintenance measure use were numbers of equids and horse-days on the operation, average ag...
Use of a virulence-associated protein based enzyme-linked immunosorbent assay for Rhodococcus equi serology in horses.
Equine veterinary journal    September 1, 1996   Volume 28, Issue 5 344-349 doi: 10.1111/j.2042-3306.1996.tb03103.x
Prescott JF, Fernandez AS, Nicholson VM, Patterson MC, Yager JA, Viel L, Perkins G.An enzyme-linked immunosorbent assay (ELISA) was developed against Rhodococcus equi using Triton X-114 detergent extracted whole cell material, in which the virulence associated protein (VapA) predominated. Enzymelinked immunosorbent assay titres corresponded to antibody reacting with VapA on Western blots. There was considerable variation in antibody titres of nonimmunised mares and in the time when the colostrally derived antibody of their foals had declined to low or undetectable titres. In general, antibodies in foals declined to their lowest levels at age 4-8 weeks. Seroconversion occurre...
Evaluation of vaccination of horses as a strategy to control equine monocytic ehrlichiosis.
Journal of the American Veterinary Medical Association    April 15, 1996   Volume 208, Issue 8 1290-1294 
Atwill ER, Mohammed HO.To determine whether preferentially vaccinated horses were at risk for exposure to Ehrlichia risticii, whether horses with equine monocytic ehrlichiosis (EME) were likely to have been nonvaccinated, and whether clinical severity and financial costs associated with care and treatment of EME were less for vaccinated horses with EME than for nonvaccinated horses with EME. Methods: Cross-sectional and case-control studies. Methods: Information on usage of E risticii bacterins to control EME was collected for 2,587 horses located on 511 farms throughout New York. Each horse was tested for serum ant...
Effects of equine influenza and tetanus vaccination on pulmonary function in normal and chronic obstructive pulmonary disease affected horses.
Equine veterinary journal    March 1, 1996   Volume 28, Issue 2 157-160 doi: 10.1111/j.2042-3306.1996.tb01608.x
Dixon PM, McGorum BC, Marley C, Halliwell RE, Matthews AG, Morris JR.No abstract available
Evidence for a high rate of false-positive results with the indirect fluorescent antibody test for Ehrlichia risticii antibody in horses.
Journal of the American Veterinary Medical Association    December 1, 1995   Volume 207, Issue 11 1448-1453 
Madigan JE, Rikihisa Y, Palmer JE, DeRock E, Mott J.The original objective was to determine seroprevalence of Ehrlichia risticii antibody among horses in California. On the basis of the unexpected results of the survey, an investigation into the accuracy and reproducibility of results of the indirect fluorescent antibody (IFA) test for E risticii was carried out. Methods: Prospective, seroprevalence study. Methods: Healthy horses (n = 655) and horses with clinical signs of equine monocytic ehrlichiosis (EME; n = 514) from various regions of California. Methods: The IFA test was performed. Results were compared with results of an ELISA and with ...
Distribution of equid herpesvirus-1 (EHV-1) in the respiratory tract of ponies: implications for vaccination strategies.
Equine veterinary journal    November 1, 1994   Volume 26, Issue 6 466-469 doi: 10.1111/j.2042-3306.1994.tb04051.x
Kydd JH, Smith KC, Hannant D, Livesay GJ, Mumford JA.Twelve adult ponies and 2 conventional foals were exposed to 10(6.6) TCID50 of Equid herpesvirus-1 (EHV-1), strain Ab4 and samples of respiratory tract tissues were recovered. Infectious virus in tissue homogenates was detected using susceptible cell monolayers and expression of viral antigens was monitored using indirect immunoperoxidase histochemistry of paraffin sections. The results illustrated the rapid dissemination of EHV-1 throughout the respiratory tract, with early replication in the lungs one day after exposure. Endothelial cell infection was prominent in all areas of the nasopharyn...
[Equine infectious arteritis: molecular biology, epidemiology and preventative measures].
Revue scientifique et technique (International Office of Epizootics)    September 1, 1994   Volume 13, Issue 3 845-854 
Zientara S.After a brief historical account of the outbreak of infectious arteritis of horses which occurred in 1984 in Kentucky (United States of America), the author reports on the present state of knowledge concerning the organisation of the genome of the virus. Clinical signs of the disease are described, as well as modes and routes of transmission. Finally, currently-available vaccination procedures are discussed and their value is assessed.
African horsesickness: pathogenesis and immunity.
Comparative immunology, microbiology and infectious diseases    August 1, 1994   Volume 17, Issue 3-4 275-285 doi: 10.1016/0147-9571(94)90047-7
Burrage TG, Laegreid WW.African horsesickness (AHS) is a serious, non-contagious disease of horses and other solipeds caused by an arthropod-borne orbivirus of the family Reoviridae. In horses, AHS causes three distinct clinicopathologic syndromes, the pulmonary, cardiac and fever forms of the disease. Recent work has shown that the primary determinant of the form of disease expressed by naive horses is the virulence of the virus inoculum. Horses which recover from AHS exhibit solid humoral immunity against homologous challenge. Protective antibodies appear to be directed towards neutralizing epitopes on AHS virus VP...
Duration of protective efficacy of equine influenza immunostimulating complex/tetanus vaccines.
The Veterinary record    February 12, 1994   Volume 134, Issue 7 158-162 doi: 10.1136/vr.134.7.158
Mumford JA, Jessett DM, Rollinson EA, Hannant D, Draper ME.Seven previously untreated five-month-old New Forest ponies received two doses of equine influenza immunostimulating complex vaccines, one with and one without an immunopurified tetanus toxoid component, given by deep intramuscular injection six weeks apart, followed by a booster dose without tetanus toxoid five months later. Fifteen months after the third dose of vaccine, the ponies were challenged by exposure to an aerosol of influenza A/Equine 2/Sussex/89 (H3N8), a virus isolated from a recent outbreak of influenza A/equine 2 in Britain. The challenge produced severe clinical signs of influ...
Export of stallions vaccinated against equine viral arteritis.
The Veterinary record    January 1, 1994   Volume 134, Issue 1 23 doi: 10.1136/vr.134.1.23-a
Bell RA.No abstract available
Effect of a booster vaccination against influenza and equine herpes virus on cardio-respiratory adjustments to strenuous exercise and training in thoroughbred horses.
Zentralblatt fur Veterinarmedizin. Reihe A    September 1, 1993   Volume 40, Issue 7 481-491 doi: 10.1111/j.1439-0442.1993.tb00656.x
Art T, Lekeux P.This study was conducted in order to assess whether exercise- and training-induced cardio-respiratory adjustments are modified during the 10-day period which follows a booster vaccination with an oily adjuvanted inactivated vaccine against influenza and equine herpesvirus-1 (Equiffa). Nine healthy vaccinated thoroughbred horses were used. Six were revaccinated and three were kept as control. All the horses completed a standardised exercise test (SET) that was repeated 4 times, i.e. 10 (SET1) and 2 (SET2) days before revaccination, and 2 (SET3) and 10 (SET4) days after revaccination. During the...
Strangles.
The Veterinary clinics of North America. Equine practice    August 1, 1993   Volume 9, Issue 2 365-374 doi: 10.1016/s0749-0739(17)30403-0
Timoney JF.The etiology, epizootiology, pathogenesis, and clinical presentation of strangles are described. Streptococcus equi, the causative organism, is highly host-adapted to Equidae and shows no antigenic variation. Protective immunity apparently is mediated by a combination of serum opsonic and nasopharyngeal mucosal humoral responses. Vaccines based on M protein or inactivated bacterial suspensions may reduce the clinical attack rate by 50%, a level of protection much lower than that produced during recovery from strangles.
Equine rabies.
The Veterinary clinics of North America. Equine practice    August 1, 1993   Volume 9, Issue 2 337-347 doi: 10.1016/s0749-0739(17)30400-5
Green SL.With the continued increase in the number of wildlife rabies cases reported across the United States and Canada, this disease will remain a threat to the horse as the potential for exposure to infected wildlife and other domestic animals is likely to also increase. Because there are no rapid, definitive antemortem diagnostic tests, the tentative diagnosis is based upon the variable and sometimes nonspecific clinical signs. Although the CSF analysis may be helpful in some cases, it may not be abnormal. Nor is collection of the specimen always practical in the field situation. The FAT on neural ...
Equine influenza virus from the 1991 Swedish epizootic shows major genetic and antigenic divergence from the prototype virus.
Virus research    June 1, 1993   Volume 28, Issue 3 263-272 doi: 10.1016/0168-1702(93)90026-j
Oxburgh L, Berg M, Klingeborn B, Emmoth E, Linné T.The antigenic properties of H3N8 equine influenza virus from the Swedish epizootic of 1991 differ from those of A/eq 2/Fontainebleau/79 (representative of the Swedish vaccine strain) in hemagglutination inhibition tests. The amino acid sequence of the hemagglutinin (HA) of an isolate from the 1991 outbreak was deduced from the nucleotide sequence and comparison was made to the A/eq 2/Fontainebleau/79 strain. Twenty-three amino acid substitutions were found, 10 mapping onto areas of the HA known to bind antibodies in human H3 influenza viruses. The amino acid changes together with the serologic...
Responses of ponies to equid herpesvirus-1 ISCOM vaccination and challenge with virus of the homologous strain.
Research in veterinary science    May 1, 1993   Volume 54, Issue 3 299-305 doi: 10.1016/0034-5288(93)90126-z
Hannant D, Jessett DM, O'Neill T, Dolby CA, Cook RF, Mumford JA.An experimental (ISCOM) vaccine previously shown to protect hamsters from lethal challenge with equid herpesvirus-1 (EHV-1), was tested in horses. Vaccination with EHV-1 ISCOMs induced serum antibodies to the major virus glycoproteins gp10, 13, 14, 17, 18 and 21/22a, whereas antibody responses to gp2 were weak or absent. High levels of virus neutralising antibody of long duration were induced, but did not prevent challenge infection with virus of the homologous strain. However, in the vaccinated ponies there was a significant reduction in clinical signs, nasal virus excretion and cell associat...
Pathogenicity of a thymidine kinase-deficient mutant of equine herpesvirus 1 in mice and specific pathogen-free foals.
The Journal of general virology    May 1, 1993   Volume 74 ( Pt 5) 819-828 doi: 10.1099/0022-1317-74-5-819
Slater JD, Gibson JS, Field HJ.Both intranasal (i.n.) and intracerebral (i.c.) inoculation of mice with wild-type equine herpesvirus type 1 (wt EHV-1) caused clinical signs and mortality. Virus could be recovered from target organs (turbinates, lungs and blood) for several days. By contrast, the thymidine kinase (TK)-deficient deletion mutant PR1 produced markedly less clinical disease following both i.n. and i.c. inoculation, and, in particular, no mortality occurred. PR1 did, however, establish productive infections following either route of inoculation. High titres of virus were recovered from target organs although viru...
[Equine influenza outbreaks with viral antigenic drift in Berlin 1988-1991].
Berliner und Munchener tierarztliche Wochenschrift    April 1, 1993   Volume 106, Issue 4 119-123 
Jaeschke G, Lange W.In this paper three outbreaks of equine influenza in Berlin (Germany) in the years of 1988, 1989 and 1991 are discussed, reporting mainly clinical, hematological, virological and some epizootiological aspects. We have detected variations from the traditional pattern of equine influenza, whereby the main clinical symptoms like cough or fever were absent in several cases. If cough was found, it was moist. Furthermore a mucous nasal discharge was present in a number of cases for a period of 4-5 days. Extreme neutropenia, lymphocytosis and predominantly an unchanged level of monocytes were observe...
Recommendations for African horse sickness vaccines for use in nonendemic areas.
Revue d\'elevage et de medecine veterinaire des pays tropicaux    January 1, 1993   Volume 46, Issue 1-2 77-81 
House JA.African horse sickness (AHS), which causes mortality up to 95%, is caused by orbiviruses and is transmitted by Culicoides. The goal of a control and eradication program for AHS is to prevent the spread of the virus via the biological vector. Control measures include slaughter of infected animals, housing of suspected infected animals in insect-proof stalls, and vaccination. Vaccination has played a key role in eradication when AHS occurred outside of Africa. Both modified live vaccines (MLV) and inactivated vaccines have been used to control AHS. An acceptable vaccine should be: safe, efficaci...
Equine vaccination.
The Veterinary record    September 19, 1992   Volume 131, Issue 12 271 doi: 10.1136/vr.131.12.271-b
Muirhead FS.No abstract available
Diversity of the antibody responses produced in ponies and mice against the equine influenza A virus H7 haemagglutinin.
The Journal of general virology    June 1, 1992   Volume 73 ( Pt 6) 1569-1573 doi: 10.1099/0022-1317-73-6-1569
Appleton JA, Gagliardo LF.A large panel of mouse monoclonal antibodies was produced and tested against field isolates of the equine H7N7 influenza A virus subtype. Only a limited degree of H7 haemagglutinin variation was detected. At least four antigenic sites were identified by selecting variant viruses in eggs. The limited variation in the field did not correlate with the frequency of variant viruses detected in eggs; this frequency was similar to those reported for other influenza viruses. We sought to determine whether the limited amount of variation could be correlated with an epitope-restricted antibody response ...
Vaccination of mares against equine herpesvirus-1.
The Veterinary record    March 7, 1992   Volume 130, Issue 10 211-212 doi: 10.1136/vr.130.10.211-c
Wood JL.No abstract available
Interference of maternal antibodies with the immune response of foals after vaccination against equine influenza.
The veterinary quarterly    January 1, 1992   Volume 14, Issue 1 13-17 doi: 10.1080/01652176.1992.9694319
van Maanen C, Bruin G, de Boer-Luijtze E, Smolders G, de Boer GF.The purpose of the study was twofold. First, using two groups of 22 foals each, we investigated the extent to which maternal antibodies interfere with the humoral response against equine influenza. The foals were born to mares that had been vaccinated twice yearly against influenza since 1982. Foals of group I were vaccinated three times at early ages (12, 16, and 32 weeks of age), and foals of group II were likewise vaccinated but a later ages (24, 28, and 44 weeks of age). After the first and second vaccinations, neither group showed an increase in antibodies that inhibit haemagglutination. ...
Preliminary findings for an inactivated African horsesickness vaccine using binary ethyleneimine.
Revue d'elevage et de medecine veterinaire des pays tropicaux    January 1, 1992   Volume 45, Issue 3-4 231-234 
Hassanain MM.Investigation studies on inactivated African horsesickness vaccine using binary ethyleneimine were conducted. The inactivation process of virulent type-9 strain using the above inactivant revealed complete virus inactivation at 18, 48 and 84 h post-treatment with inactivant concentrations of 0.004, 0.003 and 0.002M, respectively, without detection of residual virus. An inactivant concentration of 0.003M is recommended and no changes in viral antigenic properties were noticed in complement fixation test. The physical parameters in oil-emulsion vaccine using the incomplete Freund's adjuvant, wer...
Establishing an acceptability threshold for equine influenza vaccines.
Developments in biological standardization    January 1, 1992   Volume 79 137-146 
Mumford JA, Wood J.Shortcomings in the original methods (based on haemagglutination of erythrocytes) used to measure potency of equine influenza vaccines and antibody responses stimulated by vaccines, coupled with the lack of a reliable challenge system in the target species, has hindered progress in identifying the antigenic content required to provide protection. Reliable methods are now available for measuring the haemagglutinin (HA) content of vaccines and the antibody responses they elicit. The development of challenge systems in the target species has allowed antibody levels consistent with protection to b...
Attempts to immunoprotect adult horses, specifically pregnant mares, with commercial vaccines against clinical disease induced by equine herpesvirus-1.
Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B    August 1, 1991   Volume 38, Issue 6 432-440 doi: 10.1111/j.1439-0450.1991.tb00892.x
Bürki F, Nowotny N, Oulehla J, Schmehlik O, Möstl K, Pallan C, Rossmanith E.In a project lasting 4 years more than 300 Lipizzans, around 180 of them adults, were vaccinated systematically against Equine Herpesvirus-1 (EHV-1) and representative groups thereof were serologically controlled for their antibody responses. In part, vaccination intervals recommended on packing slips were followed, in part other intervals, implicated by intermediary results, were used. A live virus vaccine proved ineffective if humoral antibodies were present. An oil-adjuvanted vaccine proved of highest antiviral immunogenicity, but after repeated revaccinations caused severe local reactions ...
Field evaluation of a commercial M-protein vaccine against Streptococcus equi infection in foals.
American journal of veterinary research    April 1, 1991   Volume 52, Issue 4 589-592 
Hoffman AM, Staempfli HR, Prescott JF, Viel L.A double-blind randomized clinical trial was undertaken to determine the value of parenterally administered Streptococcus equi M-protein vaccine in foals during an epizootic of strangles. Weaned mixed-breed foals (n = 664) housed on 2 adjacent feed-lots (A and B) arrived over a 5-day period, 2 weeks before primary vaccination. Foals in lot B (n = 114) were randomly administered vaccine (n = 59) or saline solution (placebo; n = 55) on 3 occasions at biweekly intervals. Foals in lot A (n = 450) were given 1 dose of vaccine (n = 225) or placebo. The following clinical observations were scored bli...
1 9 10 11 12 13 15